Publication of Supplementary ProspectusSource: RNS
RNS PUBLICATION FORM
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association
Publication of Supplementary Prospectus
The following Supplementary Prospectus has been approved by the UK Listing Authority and is available for viewing:
Supplementary Prospectus dated April 18, 2017 (the "Supplementary Prospectus") relating to the U.S.$65,000,000,000 (in respect of Notes issued by JPMorgan Chase & Co.) and U.S.$25,000,000,000 (in respect of Notes issued by JPMorgan Chase Bank, National Association) Euro Medium Term Note Program of JPMorgan Chase & Co. and JPMorgan Chase Bank, National Association.
The Supplementary Prospectus should be read and construed in conjunction with the Prospectus dated September 23, 2016, as amended and supplemented by the Supplementary Prospectuses dated October 7, 2016, October 17, 2016, November 2, 2016, November 18, 2016, January 6, 2017, January 16, 2017, February 2, 2017 and March 1, 2017, and the documents incorporated by reference therein.
To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser.
This website is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.
For further information, please contact:
JPMorgan Chase & Co.
Telephone number: +001 212 270 6000
Fax number: +001 212 270 4240
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Supplementary Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom any offer contained in the Supplementary Prospectus is not addressed. Prior to relying on the information contained in the Supplementary Prospectus you must ascertain from the Supplementary Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS